FDAnews
www.fdanews.com/articles/131989-eisai-plans-sale-of-cancer-medicine-in-the-us-as-aricept-protection-ends

Eisai Plans Sale of Cancer Medicine in the US as Aricept Protection Ends

November 16, 2010
Eisai Co. will start selling its new breast-cancer treatment on Nov. 26 as its biggest drug, the Aricept treatment for Alzheimer’s disease, loses patent protection.
Bloomberg